The following points cannot be fully discussed due to the study limitations: (i) Since activation of MC1R signaling is known to suppress fibrosis in SSc pathology [24–26], it is predicted that the ligand expression is decreased and/or the receptor signal is attenuated in SSc patients compared with healthy subjects. This evidence concerns the gene MC1R and systemic sclerosis.